Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury?

Rabbinu R. Pribadi, Marcellus Simadibrata

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)

Abstract

Coronavirus disease 2019 (COVID-19) is a novel disorder caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it mainly affects the respiratory system, the pancreas could also become the virus' target. The issue regarding pancreatic involvement in COVID-19 has been raised by several researchers. They found increased serum amylase and/or lipase in COVID-19 patients, which suggested pancreatic injury. We aimed to critically review the evidence to provide insights and to answer the very question of the possibility of pancreatic injury. Current evidence shows that increased amylase and/or lipase is not necessarily a pancreatic injury in COVID-19 patients. Those increased enzymes might also be found in other clinical conditions.

Original languageEnglish
Pages (from-to)190-192
Number of pages3
JournalJGH Open
Volume5
Issue number2
DOIs
Publication statusAccepted/In press - Feb 2021

Keywords

  • amylases
  • COVID-19
  • lipase
  • pancreas

Fingerprint

Dive into the research topics of 'Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury?'. Together they form a unique fingerprint.

Cite this